Asset Management
Compare Stocks
2 / 10Stock Comparison
BEN vs IVZ
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
BEN vs IVZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Asset Management |
| Market Cap | $16.19B | $12.15B |
| Revenue (TTM) | $8.77B | $6.38B |
| Net Income (TTM) | $812M | $-243M |
| Gross Margin | 80.3% | 43.2% |
| Operating Margin | 6.9% | -10.9% |
| Forward P/E | 11.4x | 10.6x |
| Total Debt | $13.30B | $10.12B |
| Cash & Equiv. | $3.57B | $1.98B |
BEN vs IVZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Franklin Resources,… (BEN) | 100 | 165.1 | +65.1% |
| Invesco Ltd. (IVZ) | 100 | 343.2 | +243.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BEN vs IVZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BEN is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 6 yrs, beta 1.31, yield 4.3%
- 24.7% 10Y total return vs IVZ's 23.3%
- Lower volatility, beta 1.31, Low D/E 93.7%, current ratio 2.71x
IVZ carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 5.1%, EPS growth -235.6%
- 5.1% NII/revenue growth vs BEN's 3.5%
- Lower P/E (10.6x vs 11.4x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.1% NII/revenue growth vs BEN's 3.5% | |
| Value | Lower P/E (10.6x vs 11.4x) | |
| Quality / Margins | Efficiency ratio 0.5% vs BEN's 0.7% (lower = leaner) | |
| Stability / Safety | Beta 1.31 vs IVZ's 1.67 | |
| Dividends | 4.3% yield, 6-year raise streak, vs IVZ's 3.0% | |
| Momentum (1Y) | +98.8% vs BEN's +61.7% | |
| Efficiency (ROA) | Efficiency ratio 0.5% vs BEN's 0.7% |
BEN vs IVZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BEN vs IVZ — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BEN leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BEN and IVZ operate at a comparable scale, with $8.8B and $6.4B in trailing revenue. BEN is the more profitable business, keeping 6.0% of every revenue dollar as net income compared to IVZ's -4.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $8.8B | $6.4B |
| EBITDAEarnings before interest/tax | $1.2B | $1.2B |
| Net IncomeAfter-tax profit | $812M | -$243M |
| Free Cash FlowCash after capex | $938M | $1.9B |
| Gross MarginGross profit ÷ Revenue | +80.3% | +43.2% |
| Operating MarginEBIT ÷ Revenue | +6.9% | -10.9% |
| Net MarginNet income ÷ Revenue | +6.0% | -4.4% |
| FCF MarginFCF ÷ Revenue | +10.4% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | +34.2% |
Valuation Metrics
IVZ leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, IVZ's 16.5x EV/EBITDA is more attractive than BEN's 22.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $16.2B | $12.2B |
| Enterprise ValueMkt cap + debt − cash | $25.9B | $20.3B |
| Trailing P/EPrice ÷ TTM EPS | 34.24x | -17.09x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.45x | 10.64x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 22.82x | 16.53x |
| Price / SalesMarket cap ÷ Revenue | 1.85x | 1.91x |
| Price / BookPrice ÷ Book value/share | 1.13x | 0.95x |
| Price / FCFMarket cap ÷ FCF | 17.76x | 8.43x |
Profitability & Efficiency
BEN leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
BEN delivers a 5.6% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $-2 for IVZ. IVZ carries lower financial leverage with a 0.78x debt-to-equity ratio, signaling a more conservative balance sheet compared to BEN's 0.94x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +5.6% | -1.7% |
| ROA (TTM)Return on assets | +2.5% | -0.9% |
| ROICReturn on invested capital | +1.6% | -2.3% |
| ROCEReturn on capital employed | +2.0% | -2.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.94x | 0.78x |
| Net DebtTotal debt minus cash | $9.7B | $8.1B |
| Cash & Equiv.Liquid assets | $3.6B | $2.0B |
| Total DebtShort + long-term debt | $13.3B | $10.1B |
| Interest CoverageEBIT ÷ Interest expense | 15.19x | -6.19x |
Total Returns (Dividends Reinvested)
IVZ leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IVZ five years ago would be worth $11,058 today (with dividends reinvested), compared to $10,965 for BEN. Over the past 12 months, IVZ leads with a +98.8% total return vs BEN's +61.7%. The 3-year compound annual growth rate (CAGR) favors IVZ at 22.3% vs BEN's 11.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +32.3% | +2.3% |
| 1-Year ReturnPast 12 months | +61.7% | +98.8% |
| 3-Year ReturnCumulative with dividends | +37.8% | +83.0% |
| 5-Year ReturnCumulative with dividends | +9.7% | +10.6% |
| 10-Year ReturnCumulative with dividends | +24.7% | +23.3% |
| CAGR (3Y)Annualised 3-year return | +11.3% | +22.3% |
Risk & Volatility
BEN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BEN is the less volatile stock with a 1.31 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BEN currently trades 99.1% from its 52-week high vs IVZ's 92.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.31x | 1.67x |
| 52-Week HighHighest price in past year | $31.44 | $29.61 |
| 52-Week LowLowest price in past year | $19.79 | $14.04 |
| % of 52W HighCurrent price vs 52-week peak | +99.1% | +92.4% |
| RSI (14)Momentum oscillator 0–100 | 75.9 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 5.1M | 5.1M |
Analyst Outlook
BEN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BEN as "Hold" and IVZ as "Hold". Consensus price targets imply 8.7% upside for IVZ (target: $30) vs -7.7% for BEN (target: $29). For income investors, BEN offers the higher dividend yield at 4.26% vs IVZ's 3.04%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $28.75 | $29.72 |
| # AnalystsCovering analysts | 27 | 28 |
| Dividend YieldAnnual dividend ÷ price | +4.3% | +3.0% |
| Dividend StreakConsecutive years of raises | 6 | 4 |
| Dividend / ShareAnnual DPS | $1.33 | $0.83 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +15.3% |
BEN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IVZ leads in 2 (Valuation Metrics, Total Returns).
BEN vs IVZ: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BEN or IVZ a better buy right now?
For growth investors, Invesco Ltd.
(IVZ) is the stronger pick with 5. 1% revenue growth year-over-year, versus 3. 5% for Franklin Resources, Inc. (BEN). Franklin Resources, Inc. (BEN) offers the better valuation at 34. 2x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Franklin Resources, Inc. (BEN) a "Hold" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BEN or IVZ?
On forward P/E, Invesco Ltd.
is actually cheaper at 10. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — BEN or IVZ?
Over the past 5 years, Invesco Ltd.
(IVZ) delivered a total return of +10. 6%, compared to +9. 7% for Franklin Resources, Inc. (BEN). Over 10 years, the gap is even starker: BEN returned +24. 7% versus IVZ's +23. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BEN or IVZ?
By beta (market sensitivity over 5 years), Franklin Resources, Inc.
(BEN) is the lower-risk stock at 1. 31β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 28% more volatile than BEN relative to the S&P 500. On balance sheet safety, Invesco Ltd. (IVZ) carries a lower debt/equity ratio of 78% versus 94% for Franklin Resources, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BEN or IVZ?
By revenue growth (latest reported year), Invesco Ltd.
(IVZ) is pulling ahead at 5. 1% versus 3. 5% for Franklin Resources, Inc. (BEN). On earnings-per-share growth, the picture is similar: Franklin Resources, Inc. grew EPS 7. 1% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BEN or IVZ?
Franklin Resources, Inc.
(BEN) is the more profitable company, earning 6. 0% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 6. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BEN leads at 6. 9% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — BEN leads at 80. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BEN or IVZ more undervalued right now?
On forward earnings alone, Invesco Ltd.
(IVZ) trades at 10. 6x forward P/E versus 11. 4x for Franklin Resources, Inc. — 0. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IVZ: 8. 7% to $29. 72.
08Which pays a better dividend — BEN or IVZ?
All stocks in this comparison pay dividends.
Franklin Resources, Inc. (BEN) offers the highest yield at 4. 3%, versus 3. 0% for Invesco Ltd. (IVZ).
09Is BEN or IVZ better for a retirement portfolio?
For long-horizon retirement investors, Franklin Resources, Inc.
(BEN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4. 3% yield). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BEN: +24. 7%, IVZ: +23. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BEN and IVZ?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.